Bookmark and Share

Full Court Confirms Enantiomers Patentable, But Removes Extension of Term

Issued: August 01 2009

In a widely-watched case, Australia’s Full Federal Court has handed down its decision in H Lundbeck v. Alphapharm. Catherine McGill, Christina Taylor and Kim O’Connell explain the significance of the court’s decision.

 

Related Articles

  • Take Back
    Invalidation can be a valuable tool for IP owners to use when defending their patents. Johnny Chan examines useful invalidation strateg...
  • The Rise of Ad Blocking
    Ad blocking has emerged as the hot topic in the digital advertising industry. Richard S. Eisert and Truan Savage explain how agencies, ...
  • Patent 10 Million
    Experts across Asia and the Pacific take Johnny Chan to see the latest in patent work in their jurisdictions – and whether they are clo...
  • Domain names as IP
    Domain names are part of a company’s intangibles and have become a valuable intellectual property. Jannik Skou and Casper Thomsen explo...
  • Copyright Strategies for Start-up Compan...
    One of the most common mistakes start-up companies make is failing to shore up — in writing – ownership rights to content created for t...
  • PCT Applications in China: Increasing Va...
    Industry leaders have proven strategies for prospering in challenging times. The present economic difficulties will pass, but companies...
 

Law Firms